In this study, NRG1 fusions were observed in lung cancer, colorectal cancer, breast cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, prostate cancer, and medulloblastoma. Here, NRG1 is linked to liver cancer.